Michael Wilkinson
@MWilkinsonMD
Followers
1K
Following
1K
Media
73
Statuses
477
Preventive cardiologist, lipidologist, and clinical researcher @UCSDHealth @UCSDMedSchool
Joined October 2014
🔥Immune-mediated inflammatory diseases & dyslipidemia intersect, drive CV risk 🏃♀️💊Targeted prevention can make a difference @DrMichaelShapir
@atvbahajournals
@garshick @Bweber04 @CBallantyneMD @DrMarthaGulati @JohnKastelein @mdavidsonmd @lipiddoc
https://t.co/Ks5S37uEaF
ahajournals.org
Individuals with autoimmune inflammatory diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and psoriasis, are at increased risk for cardiovascular disease. While these diseases...
5
15
51
Join us on 28th at 8 pm ET to learn about this uncommon but fascinating lipid disorder with a stellar cast of @aremaley1 @GuyMintzMD and Dan Soffer @PennCardiology @PennMedicine @UofLCardiology @kentuckyacc @lipiddoc @lipid @drpablocorral @DrRSRosenson @Dr_Zahid_Ahmad
📣October's Lipid Panel: Diagnosis and Management of Patients with Lipoprotein X 📅 Tuesday, Oct. 28, 2025 | 🕗 8:00 PM ET Join this month's panel for an interactive, case-based discussion on Lipoprotein X and practical clinical management. Earn CME/CE! 👉 Register now:
0
1
16
Congrats to my mentee and interventional cardiology fellow, @rsampathkumarMD for leading this paper examining the impact of cardiometabolic risk factors on hemodynamic valve deterioration after TAVR. We need more research on how cardiometabolic factors contribute to valve
jacc.org
4
8
55
Congrats @PamTaubMD, such an incredible honor and so well-deserved. Thank you for your leadership & mentorship. @CBallantyneMD @rblument1 @EugeniaGianos @ProfKausikRay @Drroxmehran @PamelaBMorris @RonBlankstein @pnatarajanmd @CMichaelGibson @dramitkhera
https://t.co/zYQc4weciD
today.ucsd.edu
Pam Taub, M.D., has been appointed as the inaugural holder of the Step Family Foundation Endowed Director’s Chair in Cardiovascular Rehabilitation and Wellness, established by the Step Family and...
14
5
45
Scariest thing this Halloween? 👀 🎃 Lp(a) is elevated in millions… but <1% ever get tested! Congrats @MattRamsisMD on your new paper uncovering this chilling reality! Check it out ⬇️
Congrats to my mentee @MattRamsisMD for leading this paper examining trends in Lp(a) testing. https://t.co/XKCOWhFA3A Testing has increased, but it is still very low (less than 1% of the population). Per @nationallipid and @society_eas and @escardio guidelines everyone
1
1
6
💃🫀Congrats @AKulkarniMD for planning this important session Women’s CV health #NLAFall Fantastic, actionable talks by @DrDastmalchi & @PSatishMD
@nationallipid @foundationofnla @LipidJournal @MHealthTeam @CBallantyneMD @PamTaubMD @EugeniaGianos @DrGermanMD @DrMichaelShapir
0
6
27
CETPi with obicetrapib is primarily a therapy for reducing LDL-C and thus atherosclerotic cardiovascular disease. Our latest publication shows attenuation of emerging biomarker of Alzheimer’s disease. Exciting first steps https://t.co/JJRyk6t26S
0
21
52
High-yield, clinically focused talk by @ArchnaBajajMD - Familial Hypercholesterolemia - Masters in Lipidology #NLAFall #KnowFH @nationallipid @foundationofnla @FamilyHeartFdn @CBallantyneMD @lipiddoc @DrSafarova @DrMichaelShapir @tmodarressi
0
7
33
Congrats to my mentee @MattRamsisMD for leading this paper examining trends in Lp(a) testing. https://t.co/XKCOWhFA3A Testing has increased, but it is still very low (less than 1% of the population). Per @nationallipid and @society_eas and @escardio guidelines everyone
jacc.org
2
10
59
Great, high-yield session on diet by @carolkirkpat3 emphasis on high-quality, heart-healthy diet styles- Masters in Lipidology #NLAFall @nationallipid @LipidJournal @foundationofnla @lipiddoc @mpetersenmdphd @CBallantyneMD @PamTaubMD @ArchnaBajajMD @DrMichaelShapir @DrNathanWong
1
3
21
Fantastic session by Dr. Kevin Maki on emerging lipid-lowering therapies at #NLAFall Masters in Lipidology course. A lot to look forward to in treating lipid disorders. @nationallipid @LipidJournal @foundationofnla @lipiddoc @carolkirkpat3 @ArchnaBajajMD @mdavidsonmd @PamTaubMD
0
3
19
What are the trends in Lp(a) testing? Out now from the @UCSDCardiology BEACON Center. Congrats @MattRamsisMD @PamTaubMD @hsbhatia @MWilkinsonMD @UCSDHealth @ucsdactri
https://t.co/0CidKsDVC1
jacc.org
0
1
3
Join us on Fri, Feb 6, for an all-virtual symposium about Lp(a) hosted by the Penn Lipid Clinic. Great topics and speakers! Register at https://t.co/7aeC7nNDNV
@dan_soffer @MarlysLPA @MWilkinsonMD @Lpa_Doc @ErinMichos @MGLevin @grsoffer @DrMichaelShapir
0
3
9
Celebrate LDL-C Awareness Day tomorrow by joining The Lipid Panel! This month’s webinar, “LDL: Is It Really That Simple?” will walk through the NLA’s LDL-C management guidelines & real-world case studies. ✅ Stay current on the latest in lipidology ✅ Gain practical insights
0
6
17
Great news! @UCSDCardiology @FamilyHeartFdn @ASPCardio @CBallantyneMD @lipiddoc @ArchnaBajajMD @tmodarressi @mdavidsonmd @EugeniaGianos @hsbhatia @PamTaubMD @EKDuranMD @EugeniaGianos @Priyeshabijlani
Amazing news for pediatric HoFH patients: Evkeeza® (evinacumab-dgnb), an ANGPTL3 antibody, has been FDA-approved for children as young as 1 year old. Read the press release: https://t.co/oTXLZ9hc3J
#KnowHoFH #CholesterolMonth
0
2
8
New publication from @EKDuranMD @JAHA_AHA: @ucsdhealth @UCSDHealthSci @UCSDCardFellows
@UCSDCardFellows
https://t.co/fBDsf9GYh0
ahajournals.org
0
2
2
A new study just published highlights the increasing but low rates of testing for lipoprotein(a) or Lp(a) in 300 million individuals across the US from 2015-2024 @UCSDHealthSci @UCSDHealth @MattRamsisMD @hsbhatia @PamTaubMD @MWilkinsonMD
https://t.co/IYAUpUmUOZ
today.ucsd.edu
Researchers from UC San Diego School of Medicine found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, despite modest increases over...
1
3
9
New in JACC: Advances: Lp(a) testing is still rare nationwide, despite its role in cardiac risk. We analyzed trends using 300M+ patients in Epic Cosmos. ➡️ UCSD’s and University of California’s 1st Cosmos paper ➡️ BEACON’s 1st study 🚀 Press release 👉
today.ucsd.edu
Researchers from UC San Diego School of Medicine found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, despite modest increases over...
3
6
10
For individuals living with FH or high Lp(a), lipoprotein apheresis can be lifesaving. On #ApheresisAwarenessDay, let’s raise the volume so more people know this treatment exists. #KnowFH #KnowLpa #KnowHoFH #FHAwarenessDay #CholesterolEducationMonth
0
2
8
Join us! @FamilyHeartFdn @lipiddoc @UCSDCardiology @UCSDHealth @PamTaubMD @hsbhatia @AlisonMooreMD @DrMichaelShapir @CBallantyneMD
The Lipid Panel is BACK on LDL-C Awareness Day (Sept. 30)!🎉 This month’s webinar, “LDL: Is It Really That Simple?” will cover the NLA’s LDL-C management guidelines & real-world case studies. ✅ Stay current on the latest in lipidology ✅ Gain applicable insights for your
0
1
9
Intermittent fasting / time-restricted eating for cardiometabolic health - part of lifestyle-based strategies Thanks @UofCalifornia for chance to discuss & share our work @PamTaubMD @EmilyManoogian @SatchinPanda @UCSDHealth @UCSDCardiology @salkinstitute
https://t.co/aVXRqAaeH3
uctv.tv
Michael J. Wilkinson, M.D., F.A.C.C., F.N.L.A., explores the science and clinical evidence behind intermittent fasting and its role in promoting cardiometabolic health. He explains how aligning...
0
3
10